ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.896,50
-0,14%
S&P 500
5.064,20
0,91%
Dow Jones
38.225,66
0,85%
Euro vs US Dollar
1,07349
0,05%
Bitcoin
59.667,85
0,92%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Arcellx Inc (ACLX)

  7. Arcellx Inc (ACLX) News

ACLX Arcellx Inc

53,29
1,11 (2,13%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Arcellx Inc ACLX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
1,11 2,13% 53,29 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
52,46 51,32 54,05 53,29 52,18
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
04.4.202422:00BWArcellx to Participate in the 23rd Annual Needham Virtual..
20.3.202421:00BWArcellx to Participate at the H.C. Wainwright 2nd Annual..
08.3.202400:23EDGAR2Form 144 - Report of proposed sale of securities
29.2.202422:00PRNUSArcellx to Participate at the TD Cowen 44th Annual Health..
28.2.202422:02EDGAR2Form 8-K - Current report
28.2.202422:00PRNUSArcellx Provides Fourth Quarter and Year-End 2023 Financial..
14.2.202423:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202401:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202403:41EDGAR2Form 144 - Report of proposed sale of securities
31.1.202422:19EDGAR2Form 8-K - Current report
08.1.202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202402:24EDGAR2Form 144 - Report of proposed sale of securities
05.1.202402:23EDGAR2Form 144 - Report of proposed sale of securities
05.1.202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.1.202401:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202422:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
29.12.202300:06EDGAR2Form 144 - Report of proposed sale of securities
28.12.202322:47EDGAR2Form 8-K - Current report
19.12.202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202322:33EDGAR2Form 144 - Report of proposed sale of securities
18.12.202322:16EDGAR2Form SC 13D/A - General statement of acquisition of..
14.12.202323:52EDGAR2Form 144 - Report of proposed sale of securities
12.12.202313:37EDGAR2Form 8-K - Current report
08.12.202323:16EDGAR2Form 8-K - Current report
08.12.202322:00PRNUSArcellx Announces Continued Robust Long-Term Responses from..
15.11.202314:30DJNArcellx Shares Rise Premarket on Expanded Gilead..
15.11.202312:58DJNGilead Invests Further in Arcellx, Extends Collaboration
15.11.202312:16EDGAR2Form 8-K - Current report
15.11.202312:00BWKite and Arcellx Announce Expansion in Strategic Partnership
13.11.202322:05EDGAR2Form 8-K - Current report
13.11.202322:00PRNUSArcellx Provides Third Quarter 2023 Financial Results and..
02.11.202314:13EDGAR2Form 8-K - Current report
02.11.202314:00PRNUSArcellx Announces Oral Presentation for Its CART-ddBCMA..
26.10.202322:00PRNUSArcellx to Participate in Two Upcoming Investor Conferences
14.8.202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202322:06EDGAR2Form 8-K - Current report
14.8.202322:00PRNUSArcellx Announces Partial Clinical Hold Lifted on iMMagine-1..
07.8.202322:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.8.202322:14EDGAR2Form 144 - Report of proposed sale of securities
21.7.202322:44EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06.7.202302:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.7.202319:27EDGAR2Form 144 - Report of proposed sale of securities
20.6.202312:57DJNArcellx Shares Drop After Patient Death Draws Clinical Hold..
20.6.202301:46PRNUSArcellx Announces Clinical Hold for its iMMagine-1 Phase 2..
08.5.202322:00PRNUSArcellx Provides First Quarter Financial Results

Kürzlich von Ihnen besucht

NASDAQ
ACLX
Arcellx
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten